+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Danaher Corp (DHR) - Financial and Strategic SWOT Analysis Review

Danaher Corp (DHR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Danaher Corp (Danaher) designs, manufactures, and markets medical products and services. It offers a wide range of testing instruments, medical diagnostic solutions, life science research tools, professional microscopes, reagents and mass spectrometry, genomic consumables, filtration and flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization businesses. The company operates manufacturing, sales, distribution, service and administrative facilities in Europe, Australia, Asia, and the Americas. The company distributes its products to customers in the Americas; Europe, the Middle East, Africa, and Asia-Pacific through direct sales personnel and independent distributors. Danaher is headquartered in Washington DC, the US.

Danaher Corp Key Recent Developments

  • Mar 21, 2024: Danaher Schedules First Quarter 2024 Earnings Conference Call
  • Feb 27, 2024: Danaher to Present at TD Cowen Health Care Conference
  • Jan 09, 2024: Danaher, Jennifer Doudna, and Innovative Genomics Institute Launch Danaher-IGI Beacon for CRISPR Cures with Aim to Address Hundreds of Diseases Using Gene-editing Platform Solution
  • Dec 21, 2023: Danaher Schedules Fourth Quarter 2023 Earnings Conference Call

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Danaher Corp - Key Facts
  • Danaher Corp - Key Employees
  • Danaher Corp - Key Employee Biographies
  • Danaher Corp - Major Products and Services
  • Danaher Corp - History
  • Danaher Corp - Company Statement
  • Danaher Corp - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Business Unit
Section 2 - Company Analysis
  • Company Overview
  • Danaher Corp - Business Description
  • Business Segment: Biotechnology
  • Overview
  • Performance
  • Business Segment: Diagnostics
  • Overview
  • Performance
  • Business Segment: Life Sciences
  • Overview
  • Performance
  • Geographical Segment: All other (each country individually less than 5% of total sales)
  • Performance
  • Geographical Segment: China
  • Performance
  • Geographical Segment: United States
  • Performance
  • R&D Overview
  • Danaher Corp - Corporate Strategy
  • Danaher Corp - SWOT Analysis
  • SWOT Analysis - Overview
  • Danaher Corp - Strengths
  • Danaher Corp - Weaknesses
  • Danaher Corp - Opportunities
  • Danaher Corp - Threats
  • Danaher Corp - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences, Oil & Gas Financial Deals and Alliances
  • Danaher Corp, Medical Equipment, Deals By Year, 2018 to YTD 2024
  • Danaher Corp, Medical Equipment, Deals By Type, 2018 to YTD 2024
  • Danaher Corp, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Mar 21, 2024: Danaher Schedules First Quarter 2024 Earnings Conference Call
  • Feb 27, 2024: Danaher to Present at TD Cowen Health Care Conference
  • Jan 09, 2024: Danaher, Jennifer Doudna, and Innovative Genomics Institute Launch Danaher-IGI Beacon for CRISPR Cures with Aim to Address Hundreds of Diseases Using Gene-editing Platform Solution
  • Dec 21, 2023: Danaher Schedules Fourth Quarter 2023 Earnings Conference Call
  • Oct 31, 2023: Danaher appoints Christopher Riley to Executive Vice President for Biotechnology
  • Oct 24, 2023: Danaher Reports Third Quarter 2023 Results
  • Aug 31, 2023: Danaher and Veralto to Webcast Investor and Analyst Meeting
  • Aug 16, 2023: Danaher Releases 2023 Sustainability Report
  • Jul 25, 2023: Danaher Reports Second Quarter 2023 Results
  • May 01, 2023: Aldevron announces expansion of mRNA production capability
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Danaher Corp, Key Facts
  • Danaher Corp, Key Employees
  • Danaher Corp, Key Employee Biographies
  • Danaher Corp, Major Products and Services
  • Danaher Corp, History
  • Danaher Corp, Subsidiaries
  • Danaher Corp, Business Unit
  • Danaher Corp, Key Competitors
  • Danaher Corp, Ratios based on current share price
  • Danaher Corp, Annual Ratios
  • Danaher Corp, Annual Ratios (Cont...1)
  • Danaher Corp, Annual Ratios (Cont...2)
  • Danaher Corp, Interim Ratios
  • Danaher Corp, Medical Equipment, Deals By Year, 2018 to YTD 2024
  • Danaher Corp, Medical Equipment, Deals By Type, 2018 to YTD 2024
  • Danaher Corp, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Danaher Corp, Performance Chart (2019 - 2023)
  • Danaher Corp, Ratio Charts
  • Danaher Corp, Medical Equipment, Deals By Year, 2018 to YTD 2024
  • Danaher Corp, Medical Equipment, Deals by Type, 2018 to YTD 2024

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Roche Diagnostics International Ltd
  • Agilent Technologies Inc
  • Thermo Fisher Scientific Inc
  • Siemens Healthineers AG
  • Harvard Bioscience Inc